Discovery Life Sciences (Discovery) scientists pioneered the development of cryopreserved dissociated cells from both diseased and normal solid tissues, establishing a transformative tool for oncology research. Dissociated Tumor and Tissue Cells (DTCs) preserve the cellular complexity and molecular integrity of the tumor microenvironment (TME), enabling comprehensive studies without logistical burdens, high cost, and delays associated with sourcing and processing fresh tissue.